Low-dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke

Archives of Physical Medicine and Rehabilitation

Volumn 79, Issue 5, 1998, Pages 532-535

  Reiter, Frank ^a,b   Danni, Maura ^a   Lagalla, Giovanni ^a   Ceravolo, Gabriella ^a   Provinciali, Leandro ^a,c  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c Azienda Ospedaliera Umberto I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ANKLE; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; FEMALE; GAIT; HEMIPARESIS; HUMAN; JOINT MOBILITY; MALE; PES EQUINOVARUS; PHYSIOTHERAPY; SPASTICITY; STROKE; TIBIALIS POSTERIOR MUSCLE; TREATMENT OUTCOME;

EID: 0031945143     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(98)90068-5     Document Type: Article

References (31)

1. Skeil DA, Barnes MP. The local treatment of spasticity. Clin Rehabil 1994;8:240-6.
2. Das TK, Park DM. Botulinum toxin in treating spasticity. Br J Clin Pract 1989;43:401-2.
3. Snow BJ, Tsui JK, Bhatt MH, Varelas M, Hashimoto SA, Calne DB. Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol 1992;28:512-5.
4. Hesse S, Friedrich H, Domasch C, Mauritz KH. Botulinum toxin therapy for upper limb flexor spasticity: preliminary results. J Rehabil Sci 1992;5:98-101.
5. Hesse S, Luecke D, Malezic M, Bertelt C, Friedrich H, Gregoric M, et al. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry 1994;57:1321-4.
6. Hesse S, Jahnke MT, Luecke D, Mauritz KH. Short-term electrical stimulation enhances the effectiveness of botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett 1995;201:37-40.
7. Hesse S, Krajnik MS, Luecke D, Jahnke MT, Gregoric M, Mauritz KH. Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients. Stroke 1996;27:455-60.
8. Dengler R, Neyer U, Wohlfarth K, Bettig U, Janzik HH. Local botulinum toxin in the treatment of spastic drop foot. J Neurol 1992;239:375-8.
9. Dunne JW, Heye N, Dunne SL. Treatment of chronic limb spasticity with botulinum toxin A. J Neurol Neurosurg Psychiatry 1995;58:232-5.
10. Grazko MA, Polo KB, Jabbari B. Botulinum toxin A for spasticity, muscle spasms, and rigidity. Neurology 1995;45:712-7.
11. Borg-Stein J, Pine ZM, Miller JR, Brin MF. Botulinum toxin for the treatment of spasticity in multiple sclerosis: new observations. Am J Phys Med Rehabil 1993;72:364-8.
12. Burbaud P, Wiart L, Dubos JL, Gaujard E, Debelleix X, Joseph PA, et al. A randomized, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psychiatry 1996;61:265-9.
13. Pierson SH, Katz DI, Tarsy D. Botulinum toxin A in the treatment of spasticity: functional implications and patient selection. Arch Phys Med Rehabil 1996;77:717-21.
14. Reiter F, Danni M, Ceravolo MG, Provinciali L. Disability changes after treatment of upper limb spasticity with botulinum toxin. J Neurol Rehabil 1996;10:47-52.
15. Simpson DM, Alexander DN, O'Brien CF, Tagliati M, Aswad AS, Leon JM, et al. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double blind, placebo-controlled trial. Neurology 1996;46:1306-10.
16. Tsui JK, O'Brien CF. Clinical trials for spasticity. In: Jankovic J, Hallett M, editors. Therapy with botulinum toxin. New York: Marcel Dekker; 1994. p. 523-34.
17. Bhakta BB, Cozens JA, Bamford JM, Chamberlain MA. Use of botulinum toxin in stroke patients with severe upper limb spasticity. J Neurol Neurosurg Psychiatry 1996;61:30-5.
18. Pullman SL, Greene P, Fahn S, Pedersen SF. Approach to the treatment of limb disorders with botulinum toxin A. Arch Neurol 1996;53:617-24.
19. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987;67:206-7.
20. Wade DT, Wood VA, Heeler A, Maggs J, Langton Hewer R: Walking after stroke: measurement and recovery over the first three months. Scand J Rehabil Med 1987;19:25-30.
21. Ryerson S. The foot in hemiplegia. In: Hunt G, editor. The foot and ankle in physical therapy. New York: Churchill Livingstone; 1987.
22. Rasch PJ, Burke RK. Kinesiology and applied anatomy. 6th ed. Philadelphia (PA): Lea & Febiger; 1978.
23. Griffin JW. Use of proprioceptive stimuli in therapeutic exercise. Phys Ther 1974;54:1072-9.
24. Booth BJ, Doyle M, Montgomery J. Serial casting for the management of spasticity in the head injured adult. Phys Ther 1983;63:1960-6.
25. Shaari CM, Sanders I. Assessment of the biological activity of botulinum toxin. In: Jankovic J, Hallett M, editors. Therapy with botulinum toxin. New York: Marcel Dekker; 1994. p. 159-70.
26. Newman LB, Arieff AJ, Wasserman RR. Present status in the management of spasticity and spasm: preliminary report. Arch Phys Med Rehabil 1954;35:427-36.
27. King T. Plaster splinting as a means of reducing elbow flexor spasticity. Am J Occup Ther 1982;36:671-3.
28. Zachazewski JE, Eberle ED, Fefferies M. Effect of tone inhibiting casts and orthoses on gait. Phys Ther 1982;62:453-5.
29. Hufschmidt A, Mauritz KH. Chronic transformation of muscle in spasticity: a peripheral contribution to increased tone. J Neurol Neurosurg Psychiatry 1985;48:676-85.
30. Thilmann AF, Fellows SJ, Garms E. The mechanism of spastic muscle hypertonus: variation in reflex gain over the time course of spasticity. Brain 1991:114:233-44.
31. Green P, Fahn S, Diamond B. Development of resistance to botulinum toxin type A in patients with torticollis. Mov Disord 1994;9:213-7.